ACR Recommendations for Hydroxychloroquine Management During the COVID-19 Pandemic
The American College of Rheumatology released guiding principles for the allocation, use, and management of hydroxychloroquine during the COVID-19 pandemic.
General Rheumatology
Severe COVID-19 Risk Increased With Existing Health Conditions in the US
In the US, individuals with underlying health conditions have an increased risk for severe coronavirus disease 2019.
Severe Illness Reported With Nonpharmaceutical Chloroquine Misuse for COVID-19 Prevention
The product that sickened the couple was in powder form and was labeled “for Ornamental Fish Use Only.”
Influenza Vaccine Associated With Reduced Respiratory Morbidity, Mortality Risk in Autoimmune Rheumatic Diseases
Researchers investigated whether the influenza vaccine was effective in preventing respiratory morbidity, mortality, and all-cause mortality in patients with autoimmune rheumatic diseases.
Abbott’s Point-of-Care COVID-19 Test Delivers Results Within Minutes
The FDA has issued an Emergency Use Authorization for the Abbott ID Now™ COVID-19 test, a molecular point-of-care test that delivers results within minutes.
Tofacitinib Linked to Rapid, Consistent Improvement of Pain in Rheumatic and Musculoskeletal Diseases
Researchers described the efficacy of tofacitinib in reducing pain in patients with inflammatory rheumatic and musculoskeletal diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Workers at Risk for COVID-19 Exposure Can Access Online Training
The National Institutes of Health has launched a new website with educational resources for workers at risk for exposure to COVID-19.
Combined Interventions May Reduce Number of SARS-CoV-2 Infections
Combined interventions of quarantining infected individuals and their family members can reduce the number of SARS-CoV-2 infections.
No Additional Risk for Hepatobiliary Events With Biosimilar Etanercept vs Originator in Inflammatory Joint Disease
Researchers explored the incidence rates of hepatobiliary events in the first 6 months of routine treatment with the biosimilar etanercept or an originator drug in inflammatory joint disease.
COVID-19 in Italy: Ethical, Logistic and Therapeutic Dilemmas Plague Physicians
Italy’s health care system is highly regarded, having more hospital beds per capita than the United States.
Next post in Practice Management
